Pain Management Nursing
Volume 11, Issue 2, Supplement , Pages S11-S22, June 2010

Balancing Analgesic Efficacy with Safety Concerns in the Older Patient

  • Paul Arnstein, RN, PhD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Paul Arnstein, Clinical Nurse Specialist for Pain Relief, Massachusetts General Hospital, Boston, MA.

Massachusetts General Hospital, Boston, Massachusetts

Received 13 October 2009; received in revised form 29 October 2009; accepted 14 February 2010.

Abstract 

The rapidly expanding number of aged Americans and the increasing prevalence of persistent pain in older adults create an urgent need to unravel the complexities of chronic pain management in this population. This requires health professionals to understand both normal and pathologic changes that occur within the aging body and mind, as well as how those factors affect responses to pain and pain-relieving treatments. The medical management of pharmacologic treatment for pain in older adults is often suboptimal, ranging from failing to use analgesics for patients with considerable pain to exposing older adults to potentially life-threatening toxicities, overdoses, or drug interactions. Models for safe and effective approaches to treating pain in older adults exist, but treatments must still be tailored for each individual's needs. A growing array of targeted therapies are available for managing pain, yet two or three trials of different agents within the same drug class are often needed to optimize treatment because of the considerable variability in responses to the effects of particular medications. Older adults tend to be more vulnerable to side effects and drug interactions than their younger counterparts, owing to differences in drug distribution, metabolism, and elimination. This review delineates these vulnerabilities and informs clinicians of the strategies needed to promote safe and effective use of medications to treat pain in older adults. The goal of this paper was to review specific considerations for balancing efficacy and safety in the pharmacologic treatment of persistent pain in older adults.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 STATEMENT OF CONFLICT OF INTEREST: Paul Arnstein, RN, PhD, has been paid consultant fees in the past 2 years as a Clinical (content) advisor for King Pharmaceuticals, Cephalon Pharmaceuticals, PriCara division of Ortho McNeil, Inflexxion, American Pain Foundation, the Foundation of Informed Medical Decision Making, the Nurse Practitioner Healthcare Foundation and independent education companies.Publication of this article was supported by Endo Pharmaceuticals Inc.

PII: S1524-9042(10)00034-2

doi:10.1016/j.pmn.2010.03.003

Pain Management Nursing
Volume 11, Issue 2, Supplement , Pages S11-S22, June 2010